NL-OMON54172招募中3 期
VALT28/ PRL01: Durvalumab and low-dose Prophylactic Cranial Irradiation (PCI) versus durvalumab and observation in radically treated patients with stage III non-small cell lung cancer: A phase III randomized study - NVALT28/ PRL01
ederlandse Vereniging van artsen voor Longziekten en Tuberculose0 个研究点目标入组 170 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 170
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Stage III non-small cell lung cancer without distant metastases as proven by
- •Treatment completed with concurrent chemoradiation, within 52 days before start
- •of durvalumab.
- •Eligible for durvalumab treatment in standard of care setting.
- •ECOG perfomance statust 0-1.
- •Signed and dated informed consent.
排除标准
- •Prior cranial irradiation is not allowed.
- •Any unresolved toxicity CTCAE vs 5.0 more than grade 2 from the prior
- •chemoradiation therapy.
- •Any concurrent chemotherapy, immunotherapy, biologic or hormonal therapy for
- •cancer treatment.
- •Any condition that, in the opinion of the investigator, would interfere with
- •evaluation of the study drug or interpretation of patient safety or study
- •Non-pregnant, non lactating.
研究者
相似试验
进行中（未招募）
3 期
Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28)Carcinoma, Non-Small-Cell LungNCT04597671Association NVALT Studies170
进行中（未招募）
1 期
Preoperative durvlumab treatment for patients with early small triple negative breast cancerEUCTR2020-006106-23-FRGustave Roussy200
进行中（未招募）
1 期
Impact of the combination of durvalumab (MEDI4736) plus olaparib (AZD2281) in resectable urothelial bladder cancerEUCTR2017-002765-22-ESSpanish Oncology Genitourinary Group - SOGUG29
招募中
2 期
Phase II study of Durvalumab (MEDI4736) plus Total Neoadjuvant Therapy (TNT) in locally advanced rectal cancer (The DUREC trial)2024-515240-24-00Grupo Espanol Multidisciplinar En Cancer Digestivo60
招募中
3 期
JCOG1807C: Efficacy and safety of durvalumab before and after operation after chemoradiotherapy against superior sulcus non-small cell lung cancersuperior sulcus non-small cell lung cancerJPRN-jRCTs031190223TSUBOI Masahiro79